Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 626 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, dasatinib, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Dasatinib, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Deflazacort 6 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Solution, Capsule, Injection, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Kinase Inhibitor, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 166 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Riociguat | Riociguat .5 mg/1 | Tablet, Film coatedOral | 70710-2156 | 70710-2156-0870710-2156-09 | — |
| Riociguat | Riociguat 1 mg/1 | Tablet, Film coatedOral | 70710-2157 | 70710-2157-0870710-2157-09 | — |
| Riociguat | Riociguat 1.5 mg/1 | Tablet, Film coatedOral | 70710-2158 | 70710-2158-0870710-2158-09 | — |
| Riociguat | Riociguat 2 mg/1 | Tablet, Film coatedOral | 70710-2159 | 70710-2159-0870710-2159-09 | — |
| Riociguat | Riociguat 2.5 mg/1 | Tablet, Film coatedOral | 70710-2160 | 70710-2160-0870710-2160-09 | — |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 100 mg/1 | Capsule, Extended releaseOral | 70710-1847 | 70710-1847-03 | — |
| Fluvoxamine maleate extended-release | Fluvoxamine maleate 150 mg/1 | Capsule, Extended releaseOral | 70710-1848 | 70710-1848-03 | — |
| Indocyanine green | — | Kit | 70710-2018 | 70710-2018-03 | — |
| gadobutrol | Gadobutrol 604.72 mg/mL | InjectionIntravenous | 70710-2064 | 70710-2064-06 | — |
| gadobutrol | Gadobutrol 604.72 mg/mL | InjectionIntravenous | 70710-2065 | 70710-2065-06 | — |
| gadobutrol | Gadobutrol 604.72 mg/mL | InjectionIntravenous | 70710-2066 | 70710-2066-06 | — |
| Sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | 70710-1650 | 70710-1650-06 | — |
| Sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | 70710-1651 | 70710-1651-06 | — |
| Nufymcoranibizumab-leyk | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | 70710-2172 | 70710-2172-01 | J2778 |
| Nufymcoranibizumab-leyk | Ranibizumab .5 mg/.05mL | Injection, SolutionIntravitreal | 70710-2173 | 70710-2173-01 | J2778 |
| tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | 70710-1589 | 70710-1589-0670710-1589-0770710-1589-08 | — |
| Fluorescein | Fluorescein sodium 100 mg/mL | InjectionIntravenous | 70710-2045 | 70710-2045-09 | — |
| Fluorescein | Fluorescein sodium 250 mg/mL | InjectionIntravenous | 70710-2046 | 70710-2046-09 | — |
| Verapamil hydrochloride | Verapamil hydrochloride 120 mg/1 | TabletOral | 68382-561 | 68382-0561-0168382-0561-05 | — |
| Verapamil hydrochloride | Verapamil hydrochloride 180 mg/1 | TabletOral | 68382-562 | 68382-0562-0168382-0562-05 | — |
| Verapamil hydrochloride | Verapamil hydrochloride 240 mg/1 | TabletOral | 68382-563 | 68382-0563-0168382-0563-05 | — |
| tofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-1727 | 70710-1727-0370710-1727-09 | — |
| tofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 70710-1353 | 70710-1353-0370710-1353-09 | — |
| tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | 70710-1243 | 70710-1243-0670710-1243-08 | — |
| Hydrocortisone sodium succinate | Hydrocortisone sodium succinate 100 mg/2mL | InjectionIntramuscular, Intravenous | 70710-1907 | 70710-1907-01 | — |
| Glycerol Phenylbutyrate | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | 70710-2193 | 70710-2193-05 | — |
| Calcitonin Salmon | Calcitonin salmon 200 [USP'U]/mL | Injection, SolutionIntramuscular, Subcutaneous | 70710-1875 | 70710-1875-01 | — |
| Dapagliflozin | Dapagliflozin 5 mg/1 | TabletOral | 70710-1380 | 70710-1380-0370710-1380-09 | — |
| Dapagliflozin | Dapagliflozin 10 mg/1 | TabletOral | 70710-1381 | 70710-1381-0370710-1381-09 | — |
| Methylene blue | Methylene blue 10 mg/mL | InjectionIntravenous | 70710-2083 | 70710-2083-0170710-2083-05 | — |
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 70710-2170 | 70710-2170-0370710-2170-0770710-2170-08 | — |
| Sodium phenylbutyrate | Sodium phenylbutyrate 500 mg/1 | TabletOral | 70710-2180 | 70710-2180-08 | — |
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | 70710-1584 | 70710-1584-0470710-1584-0670710-1584-08 | — |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | 70710-1585 | 70710-1585-0470710-1585-0670710-1585-08 | — |
| brivaracetam | Brivaracetam 50 mg/1 | Tablet, Film coatedOral | 70710-1586 | 70710-1586-0470710-1586-0670710-1586-08 | — |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | 70710-1587 | 70710-1587-0470710-1587-0670710-1587-08 | — |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | 70710-1588 | 70710-1588-0470710-1588-0670710-1588-08 | — |
| bosentan | Bosentan 32 mg/1 | Tablet, For suspensionOral | 70710-1508 | 70710-1508-08 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 150 mg/1 | CapsuleOral | 70710-1948 | 70710-1948-03 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 200 mg/1 | CapsuleOral | 70710-1949 | 70710-1949-03 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | 68382-609 | 68382-0609-0168382-0609-0568382-0609-10 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 100 mg/1 | TabletOral | 68382-610 | 68382-0610-0168382-0610-0568382-0610-10 | — |
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | TabletOral | 70710-1395 | 70710-1395-03 | — |
| Eltrombopag | Eltrombopag olamine 25 mg/1 | TabletOral | 70710-1396 | 70710-1396-03 | — |
| Eltrombopag | Eltrombopag olamine 50 mg/1 | TabletOral | 70710-1397 | 70710-1397-0370710-1397-07 | — |
| Eltrombopag | Eltrombopag olamine 75 mg/1 | TabletOral | 70710-1398 | 70710-1398-03 | — |
| Leuprolide Acetate | — | Kit | 70710-1769 | 70710-1769-03 | — |
| Diazepam | Diazepam 2.5 mg/.5mL | GelRectal | 70710-2078 | 70710-2078-02 | — |
| Diazepam | Diazepam 10 mg/2mL | GelRectal | 70710-2079 | 70710-2079-02 | — |
| Diazepam | Diazepam 20 mg/4mL | GelRectal | 70710-2080 | 70710-2080-02 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.